EUVIMEDEUVIMED entdecken
Crossref

Competitive inhibition of Ephrin-A1 and EphA2 binding by Perillaldehyde leads to decreased TRPM2 expression and reduced mitochondrial damage in vascular endothelial cells

Qian-Qian Wang, Cheng-Zhi Li, Hua-Dong Que, Hui-Dan Wang, Bing-Yan Mao, Peng Li, Xue Zhang, He-Qin Zhan, Mo-Li Zhu

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Qian-Qian Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Xinxiang Medical University, Xinxiang, China, 453003. Electronic address: qianqianwang@xxmu.edu.cn. Hauptthemen laut MEDLINE: TRPM Cation Channels, Mitochondria, Endothelial Cells, Receptor, EphA2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Previous studies have demonstrated that perillaldehyde (PAE) exerts cardioprotective effects in animal models. Current evidence indicates that the intervening effect of PAE in cardiovascular diseases mainly involves the regulation of endothelial Ca2+ channels, the precise molecular mechanisms remain elusive. OBJECTIVE: This study aimed to elucidate the molecular mechanisms underlying PAE-mediated endothelial protection through the establishment of endothelium-specific TRPM2 transgenic and knockout murine models. STUDY DESIGN AND METHODS: We adopted a comprehensive experimental approach and utilized the established vascular injury model to evaluate the improvement of endothelial cells. The protocol included: (1) comprehensive assessment of endothelial function through vascular reactivity tests, (2) quantification of intracellular Ca2+ dynamics using fluorescent imaging, (3) molecular biology techniques to analyze TRPM2 pathway activity and EphA2 phosphorylation status. RESULTS: Our research results show that PAE can significantly improve endothelial dysfunction in rats with vascular injury Mechanistically, we explored two novel pathways: (1) PAE effectively suppressed TRPM2-mediated Ca2+ overload through channel inhibition (2) modulated EphA2 phosphorylation, thereby attenuating mitochondrial oxidative damage. These dual mechanisms synergistically improved endothelial cell viability. CONCLUSION: This study establishes PAE as a promising endothelial protectant with a unique dual-pathway mechanism involving coordinated inhibition of TRPM2-mediated calcium dysregulation and EphA2-dependent mitochondrial dysfunction. Our findings provide novel insights into phytochemical-based cardiovascular therapeutics and suggest potential clinical applications for PAE in endothelial pathology management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPM Cation ChannelsMitochondriaEndothelial CellsReceptor, EphA2Ephrin-A1AnimalsHumansMice, KnockoutMiceRatsMaleCalciumRats, Sprague-DawleyMice, TransgenicPhosphorylationCells, Cultured

Stichwörter der Autor:innen

Endothelial injuryEphA2MitochondriaTRPM2Vascular injury

Substanzen

TRPM Cation ChannelsReceptor, EphA2Ephrin-A1CalciumTrpm2 protein, ratTRPM2 protein, mouse

Autor:innen und Institutionen

  • College of Pharmacy, Xinxiang Medical University, Xinxiang, China, 453003. Electronic address: qianqianwang@xxmu.edu.cn.
  • College of Pharmacy, Xinxiang Medical University, Xinxiang, China, 453003.
  • College of Pharmacy, Xinxiang Medical University, Xinxiang, China, 453003. Electronic address: 041130@xxmu.edu.cn.
  • College of Pharmacy, Xinxiang Medical University, Xinxiang, China, 453003. Electronic address: molizhu@xxmu.edu.cn.

Förderung

  • Natural Science Foundation of Henan Province

Zitieren

APA

Wang, Q. Q., Li, C. Z., Que, H. D., Wang, H. D., Mao, B. Y., Li, P., Zhang, X., Zhan, H. Q., & Zhu, M. L. (2025). Competitive inhibition of Ephrin-A1 and EphA2 binding by Perillaldehyde leads to decreased TRPM2 expression and reduced mitochondrial damage in vascular endothelial cells. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114688

Vancouver

Wang QQ, Li CZ, Que HD, Wang HD, Mao BY, Li P, et al. Competitive inhibition of Ephrin-A1 and EphA2 binding by Perillaldehyde leads to decreased TRPM2 expression and reduced mitochondrial damage in vascular endothelial cells. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114688

BibTeX
@article{Wang2025,
  author = {Wang, Qian-Qian and Li, Cheng-Zhi and Que, Hua-Dong and Wang, Hui-Dan and Mao, Bing-Yan and Li, Peng and Zhang, Xue and Zhan, He-Qin and Zhu, Mo-Li},
  title = {Competitive inhibition of Ephrin-A1 and EphA2 binding by Perillaldehyde leads to decreased TRPM2 expression and reduced mitochondrial damage in vascular endothelial cells},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114688}
}
Kostenlos starten →